|
[1] 王兰,朱磊,高凯,等.单克隆抗体生物治疗药物研究进展.中国药学杂志,2014,49(23):2058-2064. Wang L,Zhu L,Gao K,et al.Progress of research and development of antibody-based therapeutics.Chin Pharm J,2014,49(23):2058-2064.
[2] 高凯,陶磊,王军志,等.重组抗体药物的质量控制.中国新药杂志,2011,20(19):1848-1855. Gao K,Tao L,Wang J Z,et al.Quality control for recombinant therapeutic antibodies.Chinese Journal of New Drugs,2011,20(19):1848-1855.
[3] 钱卫珠,侯盛,李博华,等.抗HER2人源化单克隆抗体体内外抗肿瘤活性评价方法的建立.第二军医大学学报,2005,26(5):484-487. Qian W Z,Hong S, Li B H, et al.A method for evaluation of in vitro and in vivo anti tumor activity of anti Her2 humanized monoclonal antibody.Acad J Sec Mil Med Univ,2005,26(5):484-487.
[4] 张峰.DiFi细胞增殖抑制法测定抗表皮生长因子受体单克隆抗体的生物学活性.中国生物制品学杂志,2011,20(5):607-609. Zhang F. DiFi cell proliferation inhibition test for biological potency detection of anti-EGFR monoclonal antibody. Chin J Biologicals, 2011,20(5):607-609.
[5] Cullen S P, Martin S J.Caspase activation pathways: some recent progress.Cell Death and Differentiation, 2009,16(2):935-938.
[6] 刘春雨,王兰,郭玮,等.抗CD20单克隆抗体质量控制中生物学活性的趋势分析.中国生物制品学杂志,2015,28(1):58-62. Liu C Y,Wang L,Guo W,et al.Trend analysis of biological activity in quality control of anti-CD20monoclonal antibody.Chin J Biologicals, 2015, 28(1):58-62.
[7] Paul V Beum, Margaret A, Lindorfer E, et al. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.The Journal of Immunology,2008,181(4):2916-2924.
[8] 刘春雨,王兰,郭玮,等.基于报告基因的抗CD20单克隆抗体ADCC生物学活性测定方法的建立. 药学学报,2015,50(1):94-98. Liu C Y, Wang L, Guo W,et al.Development of a novel reporter gene method for determination of ADCC potency of anti-CD20 monoclonal antibody.Acta Pharmaceutica Sinica.2015,50(1):94-98.
[9] 田生和,王大坤.细胞ELISA法的建立及应用. 中国生物制品学杂志,1992, 5(1):27-29. Tian S H, Wang D K.The Development of cell ELISA and its application. Chin J Biologicals, 1992, 5(1):27-29.
[10] Louise L,Alex B,Xu R R,et al.Bioactivity determination of native and variant forms of therapeutic interferons.Journal of Biomedicine and Biotechnology,2011,1:174615-174625.
[11] Yu L,Rao C,Shi X,et al.A novel bioassay for the activity determination of therapeutic human brain natriuretic peptide(BNP). PLoS One,2012,7(11):e49934-e49942.
[12] Yang Y S,ZhouY,YuL,et al.A novel reporter gene assay for recombinant human erythropoietin(rHuEPO) pharmaceutical products.Journal of Pharmaceutical and Biomedical Analysis,2014,100(9)316-321.
[13] Zhijie J C, Denise G, Aileen P,et al.Development of a robust reporter-based ADCC assay withfrozen, thaw-and-use cells to measure Fc effector functionof therapeutic antibodies.J Immunol Methods,2014,1(414):69-81.
[14] 王兰,饶春明,李永红,等.血管内皮生长因子抑制剂生物学活性检测方法的建立.中国生物制品学杂志,2009,22(9):895-898. Wang L, Rao C M, Li Y H, et al.Development of a method for determination of biological activity of vascular endothelial growth factor trap.Chin J Biologicals,2009,22(9):895-898.
[15] Papadopoulos N, Martin J, Ruan Q, et al.Binding and neutralization of vascular endothelial growth factor(VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.Angiogenesis, 2012,15(2):171-185.
[16] Richard V, Jens M, Kenneth A,et al.CTLA-4 and PD-1 receptors inhibit T-Cell activation by distinct mechanisms.Mol Cell Biol,2005,25(21): 9543-9553.
[17] Patrick E, Anne V H,Michel V, et al.Surface plasmon resonance: principles, methods and applications in biomedical sciences.Spectroscopy,2003,17(2):255-273.
[18] Guo X.Surface plasmon resonance based biosensor technique: a review.J Biophotonics, 2012,5(7):483-501.
[19] 王兰,李永红,陶磊,等.人源化叶酸受体α抗体质控方法的建立.中国生物制品学杂志,2010,23 (9):986-989. Wang L, Li Y H, Tao L, et al.Development of a method for quality control of humanized monoclonal antibodyagainst folate receptor α.Chin JBiologicals,2010,23(9):986-989.
[20] Rossant C J,Matthews C,Neal F,et al.Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.J Biomol Screen, 2014,11(7):1-11
[21] Burlein C,Bahnck C,Bhatt T,et al.Development of a sensitive amplified luminescent proximity homogeneous assay to monitor the interactions between pTEFb and Tat.Anal Biochem, 2014,465(9):164-171.
[22] 冯国双,谭德讲,刘韫宁,等.四参数log-logistic 模型在生物活性测定研究中的应用.药物分析杂志,2013,33(11):1849-1851. Feng GS,Tan D J,Liu Y N,et al.Application of 4-parameter log-logistic model in bioassay.Chin J Pharm Anal,2013,33(11):1849-1851.
[23] 高凯,徐志凯,任跃明,等.关于我国药典单克隆抗体类生物治疗药物总论的思考.中国生物工程杂志,2014,34(1):119-125. Gao K, Xu Z K Ren Y M,et al.Points to consider for the general monograph of monoclonal antibody based biotherapeutics in Chinese pharamacopeia.China Biotechnology,2014,34(1):119125.
|
